SAPPHIRE Held Up To The Light: Surgeons Reflect On Carotid Stent Data
This article was originally published in The Gray Sheet
Executive Summary
FDA panelist Anthony Comerota, MD, is challenging carotid stent proponents to prove the technology's superiority over endarterectomy in a more relevant patient group than Johnson & Johnson/Cordis' SAPPHIRE trial enrolled